Top Markets
Coin of the day
PRF Technologies Ltd. PRF Technologies Ltd.

PRF Technologies Ltd.

PRFX
Pozycja w akcjach #40769
PRF Technologies Ltd. operates as a specialized pharmaceutical company,... PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Cena akcji
$1.03
Kapitalizacja rynkowa
$82.56K
Zmiana (1 dzień)
-0.47%
Zmiana (1 rok)
-85.86%
Kraj
IL
Handel PRF Technologies Ltd. (PRFX)

Kategoria

EPS dla PRF Technologies Ltd. (PRFX)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy PRF Technologies Ltd., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla PRF Technologies Ltd. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.